REMEDIATION OF FUNCTIONAL CARDIAC MITRAL VALVE REGURGITATION
    1.
    发明申请
    REMEDIATION OF FUNCTIONAL CARDIAC MITRAL VALVE REGURGITATION 有权
    功能性心脏瓣膜注射补救

    公开(公告)号:US20090287037A1

    公开(公告)日:2009-11-19

    申请号:US12066997

    申请日:2006-09-01

    IPC分类号: A61N1/375

    CPC分类号: A61F2/2481 A61F2/2442

    摘要: A dynamic device for reducing functional mitral regurgitation is described. The device is disposed externally to the heart and effectively acts as a splint for reducing further dilation of the heart in patients diagnosed with cardiomyopathy, and for reducing tethering of the papillary muscle on the mitral valve. The device does not require cardiopulmonary bypass for its installation since it is attached to the outside of the left ventricle, thereby reducing surgical risk, and is not exposed to the patient's blood once installed, thereby reducing the risk of thromboembolic disease.

    摘要翻译: 描述了用于减少功能性二尖瓣反流的动态装置。 该装置设置在心脏外部,并有效地用作夹板,以减少诊断为心肌病的患者心脏的进一步扩张,并减少二尖瓣上乳头肌的束缚。 该装置不需要用于其安装的体外循环,因为其连接到左心室的外部,从而降低手术风险,并且一旦安装就不会暴露于患者的血液,从而降低血栓栓塞性疾病的风险。

    Remediation of functional cardiac mitral valve regurgitation
    2.
    发明授权
    Remediation of functional cardiac mitral valve regurgitation 有权
    功能性心脏二尖瓣反流的治疗

    公开(公告)号:US08133168B2

    公开(公告)日:2012-03-13

    申请号:US12066997

    申请日:2006-09-01

    IPC分类号: A61N1/362

    CPC分类号: A61F2/2481 A61F2/2442

    摘要: A dynamic device for reducing functional mitral regurgitation is described. The device is disposed externally to the heart and effectively acts as a splint for reducing further dilation of the heart in patients diagnosed with cardiomyopathy, and for reducing tethering of the papillary muscle on the mitral valve. The device does not require cardiopulmonary bypass for its installation since it is attached to the outside of the left ventricle, thereby reducing surgical risk, and is not exposed to the patient's blood once installed, thereby reducing the risk of thromboembolic disease.

    摘要翻译: 描述了用于减少功能性二尖瓣反流的动态装置。 该装置设置在心脏外部,并有效地用作夹板,以减少诊断为心肌病的患者心脏的进一步扩张,并减少二尖瓣上乳头肌的束缚。 该装置不需要用于其安装的体外循环,因为其连接到左心室的外部,从而降低手术风险,并且一旦安装就不会暴露于患者的血液,从而降低血栓栓塞性疾病的风险。